Compare Cassava Sciences Inc (FLNA) vs Sprott Uranium Miners ETF (URNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Sprott Uranium Miners ETF — how do they compare? Cassava Sciences Inc trades at $1.08 (market cap $53.14M), while Sprott Uranium Miners ETF trades at $48.85. The key difference: Sprott Uranium Miners ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | URNM | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $4.64 | $83.99 |
52-Week Low | $1.09 | $44.14 |
Enterprise Value | -$33.43M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
URNM (Sprott Uranium Miners ETF) trades at $49.49, down 4.07% today amid bearish technical signals with all 15 moving averages indicating sell signals. The ETF provides concentrated exposure to uranium miners, benefiting from the nuclear energy revival driven by AI power demand. Recent news highlights uranium's strategic role in meeting data center electricity needs, though the sector experienced recent volatility with uranium stocks declining.
The uranium sector faces a decade-long supply-demand imbalance favoring miners, though URNM's pure-miner focus brings higher volatility. Key risks include uranium price fluctuations and miner operational challenges. Analyst sentiment is mixed with some seeing long-term opportunity while others caution about stretched valuations relative to underlying uranium prices.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Sprott Uranium Miners ETF
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →
